The Urology Group


It's Here - CyberKnife

Patient Stories


Jon's Story

As an attorney with a solo practice, Jon didn't want to let his clients down by missing a lot of time during his prostate cancer treatment. With CyberKnife completing treatments in just five session, plus minimal side effects, it was the right option for Jon. 

Read More

Tom's Story

The combination of CyberKnife's advanced technology and top quality patient care made Tom's experience with prostate cancer relatively pain-free.

Read More

Bill's Story

The Radiation Center's First Patient!

The staff at The Radiation Center of The Urology Group celebrated with Bill, the first patient to receive CyberKnife radiation treatment at our Norwood Campus. Bill completed his treatments on October 30.

Read More

Scott's Story

What he thought was an ordinary drive home from a baseball game turned out to be a defining moment in Scott’s life. He got the call: at age 61 he was diagnosed with prostate cancer.

Scott, a retired orthopedic surgeon, began extensive research on prostate cancer and the various treatments. He spoke with a number of prostate cancer patients about their treatments and the problems they encountered. Around the same time, one of Scott’s friends attended a prostate cancer seminar and brought him back information about the CyberKnife® Robotic Radiosurgery System.

Read More

Patient Help Center


Our patient portal is undergoing maintenance and is currently not available. We apologize for the inconvenience.

  • Korean War Commemoration Event
    July 27, 2018
    Korean War veterans who are also GE retirees are invited to this special event to mark the 65th anniversary of the Korean War Armistice agreement. MORE...
  • Dr. Gary Kirsh To Testify Before Congress
    July 17, 2018
    Dr. Gary Kirsh is testifying today at the House Ways and Means Committee. The Urology Group and others have been working in Congress to achieve reforms to the Stark Laws to ensure the successful transition from volume to value in the Medicare program. You can access more information on the link below. MORE...